Codexis (CDXS) Non-Current Assets (2010 - 2026)
Codexis (CDXS) posted quarterly Non-Current Assets of $49.7 million for Q1 2026, down 2.66% year-over-year from $51.1 million in Q1 2025, and down 2.47% quarter-over-quarter from $51.0 million in Q4 2025.
Codexis (CDXS) Non-Current Assets (2010 - 2026) Analysis & Trends
Codexis' Non-Current Assets history runs 17 years deep, the most recent figure standing at $49.7 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 2.66% year-over-year to $49.7 million; the TTM figure through Mar 2026 stood at $198.0 million (up 11.73% YoY), while the FY2025 annual figure was $51.0 million, up 1.48% from the prior year.
- Non-Current Assets for Q1 2026 stood at $49.7 million, down from $51.0 million in the prior quarter.
- The five-year high for Non-Current Assets was $90.4 million in Q1 2022, with the low at $35.3 million in Q3 2024.
- The 5-year median for Non-Current Assets is $51.0 million (2025), against an average of $61.4 million.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 134.17% in 2022, then plunged 53.17% in 2024.
- Codexis' Non-Current Assets stood at $87.5 million in 2022, then slumped by 50.75% to $43.1 million in 2023, then climbed by 16.58% to $50.2 million in 2024, then advanced by 1.48% to $51.0 million in 2025, then dropped by 2.47% to $49.7 million in 2026.
- Business Quant data shows CDXS's Non-Current Assets at $49.7 million in Q1 2026, $51.0 million in Q4 2025, and $47.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 18.06 Bn |
| 10 | Codexis | 148.87 Mn | 93.95 Mn | 11.40 Mn | 48.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.14 Mn |
| Mar 31, 2026 | 49.72 Mn |
| Dec 31, 2025 | 50.98 Mn |
| Sep 30, 2025 | 47.77 Mn |
| Jun 30, 2025 | 49.52 Mn |
| Mar 31, 2025 | 51.08 Mn |
| Dec 31, 2024 | 50.24 Mn |
| Sep 30, 2024 | 35.28 Mn |
| Jun 30, 2024 | 40.61 Mn |
| Mar 31, 2024 | 41.61 Mn |
| Dec 31, 2023 | 43.10 Mn |
| Sep 30, 2023 | 51.44 Mn |
| Jun 30, 2023 | 86.72 Mn |
| Mar 31, 2023 | 88.11 Mn |
| Dec 31, 2022 | 87.50 Mn |
| Sep 30, 2022 | 89.29 Mn |
| Jun 30, 2022 | 89.69 Mn |
| Mar 31, 2022 | 90.41 Mn |
| Dec 31, 2021 | 84.50 Mn |
| Sep 30, 2021 | 53.44 Mn |